Design Therapeutics annual operating margin
2020
Design Therapeutics Operating Margin Growth & History (DSGN)
Design Therapeutics's operating margin was −3,685.84% for fiscal 2020.
View full Design Therapeutics company overviewDesign Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −3,685.84% | — |
Design Therapeutics quarterly operating margin
Q1.20
Q2.20
Q3.20
Q4.20
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2020 | 2020-12-31 | −11,700.00% | — |
| Q3 2020 | 2020-09-30 | −11,915.00% | — |
| Q2 2020 | 2020-06-30 | −4,719.35% | — |
| Q1 2020 | 2020-03-31 | −438.73% | — |
Design Therapeutics operating margin trends
The latest reported quarter, Q4 2020, shows −11,700.00%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Design Therapeutics source filings ↗